Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Body hormone ghrelin, a food intake and weight gain influence, is found to promote sleep

19.03.2003


New study may have implications for millions in search of the elusive “good night’s sleep”

In movies and novels alike, much is made of the stage of sleep known as rapid eye movement (REM), since this is the phase of slumber in which dreams (good, bad, exotic) occur. Among the medical community, there is an increased appreciation for what is called “slow-wave” sleep, (also known as deep or delta-wave sleep), because this fourth stage of sleep can be difficult to attain. If one is awakened during the first three stages of sleep, they must repeat these stages again before reaching fourth stage or “delta-wave,” sleep.

Once this latter stage is reached, muscles are relaxed, blood pressure drops, and the pulse and breathing are slower. According to the Sleep Research Center, other benefits to the body are accrued during slow-wave sleep, including: an increase of blood supply to the body; a decrease in body temperature thus preserving energy; a lowering of metabolic activity enabling tissue repair and growth; an increase of natural immune-system modulators; and a period in which the growth hormone secretions reach their peak, thus stimulating body growth and development.



A New Study

A team of researchers has found that the peptide hormone ghrelin, bound to the growth hormone secretagogue (GHS) receptor, has a distinct positive action on stage four sleep and nocturnal hormone secretion. Their findings suggest that, in addition to its influence on growth hormone secretion, food intake, and weight gain, ghrelin is a sleep-promoting factor. This new role for the peptide appears to be complementary in function to its established function in the regulation of energy balance and obesity.

Previous rat studies offered conflicting data on sleep following ghrelin administration. In one study, a decrease of REM sleep was found after administration of ghrelin to rats. In another study, ghrelin was given to two different strains of mice, intact animals and those with nonfunctional growth hormone-releasing hormone receptors. Only in mice with intact growth hormone-releasing hormone receptors did NREM sleep increase after administration of the peptide.

Prior to this research, the influence of ghrelin on human sleep was unknown. A team of German researchers selected a protocol that followed previous studies on the sleep-endocrine effects of the peptide, including growth hormone-releasing hormone, GHRP-6, hexarelin, and vasoactive intestinal peptide (VIP). They investigated the effects of the systematic administration of ghrelin on sleep EEG and of GH, ACTH, cortisol, and leptin in healthy male subjects. The authors of “Ghrelin Promotes Slow-Wave Sleep in Humans” are J. C. Weikel, A. Wichniak, M. Ising, H. Brunner, E. Friess, K. Held, S. Mathias, D. A. Schmid, M. Uhr, and A. Steiger, all from the Max Planck Institute of Psychiatry, Department of Psychiatry, Munich, Germany. Their findings appear in the February 2003 edition of the American Journal of Physiology-Endocrinology and Metabolism.

Methodology

Subjects in this study were healthy male volunteers, all free of alcohol, tobacco, and caffeine abuse. The sleep-endocrine studies consisted of two sessions, separated by one week in which a placebo (saline) or ghrelin was administered according to a double-blind, randomized schedule. The experimental sessions consisted of two successive nights in the sleep laboratory. The first night allowed adaptation to the laboratory setting. On the second night, a dose of ghrelin or placebo was administered as a bolus injection through an indwelling intravenous catheter, which permitted administration of the testing drug and repeated blood collection in the adjacent laboratory without disturbing the study subject.

All subjects were reclining at 8:00 PM. Injections of ghrelin or placebo were given hourly between 10:00 PM and 1:00 AM. Blood samples were collected every 30 minutes between 8:00 and 10:00 PM, and every 20 minutes between 10:00 PM and 7:00 AM. The subjects were not allowed to sleep until the lights were turned off at 11:00 PM. Polysomnographic recordings were obtained from 11:00 PM to 7:00 AM, and consisted of two EEGs, vertical and horizontal electroculograms, and electromyogram. A hormone analysis was conducted with the drawn blood samples.

Results

On the night of ghrelin administration, the time spent in slow-wave or stage IV sleep increased significantly compared with the placebo night. Separate inspections of the three sleep-time segments showed significant increases of slow-wave sleep during the first and second thirds of the night but not during the last third. REM sleep showed a significant decrease only during the second third of the night. Intermittent wakefulness appeared to decrease, although it did not reach a level of significance. All other sleep continuity and sleep architecture variables remained unchanged.

Conclusions

This study finds that the body’s endocrine system may offer a means for the body to obtain deep sleep, that which contributes to the body’s overall health. These findings could have important implications for long-term health, since the pursuit of a “good night’s sleep” is an obsession for many Americans.



Source: February 2003 edition of the American Journal of Physiology-Endocrinology and Metabolism.

The American Physiological Society (APS) was founded in 1887 to foster basic and applied science, much of it relating to human health. The Bethesda, MD-based Society has more than 10,000 members and publishes 3,800 articles in its 14 peer-reviewed journals every year.

Donna Krupa | APS
Further information:
http://www.the-aps.org/press_room/journal/pr3-17-2.htm

More articles from Health and Medicine:

nachricht Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin

nachricht Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Strathclyde-led research develops world's highest gain high-power laser amplifier

The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.

The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

New insights into the ancestors of all complex life

29.05.2017 | Earth Sciences

New photocatalyst speeds up the conversion of carbon dioxide into chemical resources

29.05.2017 | Life Sciences

NASA's SDO sees partial eclipse in space

29.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>